Nucleotide compounds that block the bitter taste of oral...

Details Nucleotide compounds that block the bitter taste of oral... Nucleotide compounds that block the bitter taste of oral...

2005-09-13

2005-09-13

Page, Thurman K. (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

C514S023000, C514S042000, C514S045000, C514S049000

Reexamination Certificate

active

06942874

ABSTRACT:
Nucleotides that block the bitter taste of foods, beverages, pharmaceutically active oral dose preparations, cosmetics and other bitter compounds that come into contact with taste tissue. The nucleotides consist of a purine or pyrimidine group, or derivative thereof, and an ionizable phosphate or other anionic organic molecule.

REFERENCES:
patent: 4243691 (1981-01-01), Mohlenkamp, Jr., et al.
patent: 5232735 (1993-08-01), Kurtz et al.
patent: 5631038 (1997-05-01), Kurtz et al.
patent: 5631231 (1997-05-01), Kurtz et al.
patent: 5631232 (1997-05-01), Kurtz et al.
patent: 5631240 (1997-05-01), Kurtz et al.
patent: 5631252 (1997-05-01), Kurtz et al.
patent: 5631272 (1997-05-01), Kurtz et al.
patent: 5631292 (1997-05-01), Kurtz et al.
patent: 5631294 (1997-05-01), Kurtz et al.
patent: 5631295 (1997-05-01), Kurtz et al.
patent: 5631299 (1997-05-01), Kurtz et al.
patent: 5637618 (1997-06-01), Kurtz et al.
patent: 5639788 (1997-06-01), Kurtz et al.
patent: 5641795 (1997-06-01), Kurtz et al.
patent: 5641799 (1997-06-01), Kurtz et al.
patent: 5641811 (1997-06-01), Kurtz et al.
patent: 5641812 (1997-06-01), Kurtz et al.
patent: 5643894 (1997-07-01), Kurtz et al.
patent: 5643941 (1997-07-01), Kurtz et al.
patent: 5643945 (1997-07-01), Kurtz et al.
patent: 5643955 (1997-07-01), Kurtz et al.
patent: 5643956 (1997-07-01), Kurtz et al.
patent: 5646122 (1997-07-01), Kurtz et al.
patent: 5650403 (1997-07-01), Kurtz et al.
patent: 5654311 (1997-08-01), Kurtz et al.
patent: 5665755 (1997-09-01), Kurtz et al.
patent: 5700792 (1997-12-01), Kurtz et al.
patent: 5703053 (1997-12-01), Kurtz et al.
patent: 5853792 (1998-12-01), Zolotov et al.
patent: 5866608 (1999-02-01), Kurtz et al.
patent: 6008250 (1999-12-01), Kurtz et al.
patent: 6015792 (2000-01-01), Kurtz et al.
patent: 0 059 363 (1984-12-01), None
patent: 0 122 400 (1987-07-01), None
patent: 0 125 021 (1987-07-01), None
patent: 0 416 667 (1993-09-01), None
patent: S48-17044 (1973-05-01), None
patent: 11-169131 (1999-06-01), None
Adler et al.; 2000; Cell, vol. 100 pages 639-702.
Amer and Kreighbaum; 1975; Journal of Pharmaceutical Sciences, vol. 64, pp. 1-35.
Asano et al.; 1984; Biochemistry; vol. 23 pp. 5460-5467.
Birnbaumer et al.; 1990; Biochimica et Biophysica Acta, vol. 1031, pp. 163-224.
Chandrashekar et al.; 2000; Cell; vol. 100, pp. 703-711.
Gilbertson et al.; 2000; Current Opinion in Neurobiology; vol. 3, pp. 519-527.
McGregor and Gravina; 2001; 23rd Meeting of Association of Chemoreceptor Science.
Hoon et al.; 1995; Biochem J.; vol. 309, pp. 629-636.
Huang et al.; 1999; Nature Neuroscience; vol. 2, pp. 1055-1062.
Matsunami et al.; 2000; Nature; vol. 404, pp. 601-604.
Margolskee et al.; 1993; Current Opinion in Neurobiology; vol. 3, pp. 526-531.
Margolskee et al.; 1993; BioEssays; vol. 15, pp. 645-650.
Ming et al.; 1999; Proc. Natl. Acad. Sci. USA; vol. 96, pp. 9903-9908.
Ming et al.; 1998; Proc. Natl. Acad. Sci. USA; vol. 95, pp. 8933-8938.
Gravina et al.; 2001; in preparation; p. 4 of spec.
McLaughlin et al.; 1992; Nature; vol. 357, pp. 563-569.
Naim et al.: 1994; Biochem J.; vol. 297, pp. 451-454.
Rarick et al.; 1992; Science; vol. 256, pp. 1031-1033.
Rodbell et al.; 1971; The Journal of Biological Chemistry; vol. 246, pp. 1877-1882.
Ruiz-Avila et al.; 1995; Nature; vol. 376, pp. 80-85.
Ruiz-Avila et al.; 2000; Chem Senses; vol. 25, pp. 361-368.
Spielman et al.; 1994; Physiology and Behavior; vol. 56, pp. 1149-1155.
Wong et al.; 1996; Nature; vol. 381, pp. 796-800.
Tsunenari et al.; 1999; Journal of Physiology; vol. 519.2, pp. 397-484.
Dialog File 351, Accession No. 3529012, Derwent WPI English language abstract for EP 0 059 363.

Affiliated with

Also associated with

Rating

Nucleotide compounds that block the bitter taste of oral... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleotide compounds that block the bitter taste of oral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide compounds that block the bitter taste of oral... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3378769